Euro Health Leaders features Eleva and CEO Björn Cochlovius
Euro Health Leaders features Eleva and CEO Björn Cochlovius [...]
Eleva Receives Orphan Drug Designation in Europe for Proprietary Factor H Therapy in C3 Glomerulopathy (C3G)
Eleva receives Orphan Drug Designation in Europe for proprietary [...]
Webinar Four
FOUR Edition FOUR of our webinar series will zoom [...]
Webinar Three
THREE Webinar THREE is dedicated to pediatric case reports [...]
Webinar Two
TWO Webinar TWO will focus on diagnostics and the [...]
Webinar One
ONE Kicking off the 2024 webinar series, our [...]
Eleva publishes preclinical data on proprietary Factor H therapy
Eleva publishes preclinical data on proprietary Factor H therapy [...]
